Clinical Trial Update: A Study of DZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6) [Phase 3]

View source ↗

Summary

This clinical trial update notes a Phase 3 study evaluating DZD8586 versus investigator's choice in relapsed/refractory chronic lymphocytic leukemia and small l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• DZD8586

Snippet

Sponsor: Dizal (Jiangsu) Pharmaceutical Co., Ltd. | Conditions: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Phase 3 | Status: RECRUITING